Meet and get the opportunity to ask questions directly to Amniotics CEO Kåre Engkilde.

Amniotics is a pre-clinical Biopharmaceutical company with focus on Stem-cell therapy. The company is located in Lund – Sweden.

They have an interesting pipeline, technology platform and own production (GMP), so they hold the full value-chain inhouse.

The company was listed on Nasdaq First North July the 6^th. 2021 and current marketcap is 206 MSEK.